Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445105 · ClinicalTrials.gov registry record · NA
Mobilizing Community Systems to Engage Families in Early Autism Spectrum Disorder (ASD) Detection & Services
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 10,857
- Enrollment target
NCT02445105: Completed NA study, sponsored by Florida State University.
NCT02445105 is a NA study that has completed, run by Florida State University. The registered enrollment target is 10,857 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (674% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445105, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,857 participants
- Enrollment target
Study Summary
This multisite study will compare the effectiveness of universal screening by 3 community service systems using Autism Navigator, a highly interactive web platform that includes an automated screening tool, information about autism for families, and a professional development course on the early signs of autism and effective evidence-based practice with extensive video footage to rapidly build the capacity for early detection. The investigators will also conduct a multisite pragmatic randomized clinical trial to test the effectiveness of an evidence-based Family Engagement Intervention compared to Autism Navigator Enhanced Practice implemented by the 3 community service systems with children who have a positive autism screen to increase the number of children who are screened, referred for evaluation, receive a diagnosis, and receive community-based EI between 18-27 months of age. This study will impact family engagement in community screening and diagnosis by demonstrating the effectiveness of brief manualized engagement interventions. Findings will advance science by providing researchers with a method for recruiting a community sample, allowing for research at younger ages, which could accelerate science.
Primary Outcome
This is a tally of the number of children screened by each provider and then summed.
Interventions
- BEHAVIORAL Autism Navigator Enhanced Practice
- BEHAVIORAL Family Engagement plus Autism Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,857 participants |
| Start Date | 2015-12 |
| Est. Completion | 2021-06 |
| Phase | NA |
What the finished NCT02445105 record still lists
NCT02445105 is an interventional study that assigns participants to a tested intervention. Its 10,857 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (674% higher).
The record links to 0 conditions, and to 2 interventions - of which Autism Navigator Enhanced Practice is the first listed.
NCT02445105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445105 about?
NCT02445105 is a clinical study titled "Mobilizing Community Systems to Engage Families in Early Autism Spectrum Disorder (ASD) Detection & Services". This multisite study will compare the effectiveness of universal screening by 3 community service systems using Autism Navigator, a highly interactive web platform that includes an automated screening tool, information about autism for families, and a professional development course on the early sig...
What is the current status of trial NCT02445105?
This trial is currently completed. It is a NA study. The enrollment target is 10,857 participants. The study started on 2015-12. Estimated completion is 2021-06.
What interventions are being tested in trial NCT02445105?
The interventions under investigation include: Autism Navigator Enhanced Practice (BEHAVIORAL), Family Engagement plus Autism Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT02445105?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02445105's enrollment target sits among peer trials
10,857 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia